Regenerative Medicine: Biomaterials and Stem Cell Research: 2nd Edition
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Materials Science".
Deadline for manuscript submissions: 30 April 2026
Special Issue Editor
Interests: tissue engineering; regenerative medicine; cell therapy; bioprinting; stem cells
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Regenerative medicine is an emerging field that combines biomaterials and stem cells to repair, replace, or regenerate damaged tissues and organs. Biomaterials provide structural and biochemical support that facilitates tissue regeneration. They are designed to be biocompatible and, in many cases, biodegradable, allowing them to integrate safely into the body.
Stem cells, with their unique ability to differentiate into various types of specialized cells, are essential in this field. These cells can be obtained from various sources, including embryonic, adult, and induced pluripotent stem cells (iPSCs). Current research focuses on optimizing the conditions for the growth and differentiation of these cells in combination with suitable biomaterials.
This Special Issue aims to highlight both basic and clinical studies that incorporate biomolecular experiments to provide a more complete understanding of how the integration of biomaterials and stem cells in regenerative medicine is revolutionizing the treatment of degenerative diseases, severe injuries, and the shortage of organs for transplantation, offering new hope for improving patients' quality of life.
Dr. Silvia María Díaz-Prado
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- regenerative medicine
- stem cell
- biomaterial
- bioprinting
- tissue engineering
- tissue and organ transplant
- organ scarcity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
